These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 9140802

  • 1. A dose-response trial of nebivolol in essential hypertension.
    Van Nueten L, Dupont AG, Vertommen C, Goyvaerts H, Robertson JI.
    J Hum Hypertens; 1997 Feb; 11(2):139-44. PubMed ID: 9140802
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW.
    Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
    [Abstract] [Full Text] [Related]

  • 3. Adding nebivolol to ongoing antihypertensive therapy improves blood pressure and response rates in patients with uncontrolled stage I-II hypertension.
    Neutel JM, Smith DH, Gradman AH.
    J Hum Hypertens; 2010 Jan; 24(1):64-73. PubMed ID: 19404314
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.
    Giles TD, Weber MA, Basile J, Gradman AH, Bharucha DB, Chen W, Pattathil M, NAC-MD-01 Study Investigators.
    Lancet; 2014 May 31; 383(9932):1889-98. PubMed ID: 24881993
    [Abstract] [Full Text] [Related]

  • 5. Comparison of Nebivolol monotherapy versus Nebivolol in combination with other antihypertensive therapies for the treatment of hypertension.
    Papademetriou V.
    Am J Cardiol; 2009 Jan 15; 103(2):273-8. PubMed ID: 19121451
    [Abstract] [Full Text] [Related]

  • 6. Comparative effects of a two-week treatment with nebivolol and nifedipine in hypertensive patients suffering from COPD.
    Cazzola M, Matera MG, Ruggeri P, Sanduzzi A, Spicuzza L, Vatrella A, Girbino G.
    Respiration; 2004 Jan 15; 71(2):159-64. PubMed ID: 15031571
    [Abstract] [Full Text] [Related]

  • 7. Nebivolol, but not metoprolol, lowers blood pressure in nitric oxide-sensitive human hypertension.
    Okamoto LE, Gamboa A, Shibao CA, Arnold AC, Choi L, Black BK, Raj SR, Robertson D, Biaggioni I.
    Hypertension; 2014 Dec 15; 64(6):1241-7. PubMed ID: 25267802
    [Abstract] [Full Text] [Related]

  • 8. Comparison of antihypertensive efficacy of carvedilol and nebivolol in mild-to-moderate primary hypertension: a randomized trial.
    Erdoğan O, Ertem B, Altun A.
    Anadolu Kardiyol Derg; 2011 Jun 15; 11(4):310-3. PubMed ID: 21543293
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of nebivolol in Hispanics with stage I-II hypertension: a randomized placebo-controlled trial.
    Punzi H, Lewin A, Lukić T, Goodin T, Wei Chen.
    Ther Adv Cardiovasc Dis; 2010 Dec 15; 4(6):349-57. PubMed ID: 21088095
    [Abstract] [Full Text] [Related]

  • 10. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
    Weiss RJ, Stapff M, Lin Y.
    Am J Cardiovasc Drugs; 2013 Apr 15; 13(2):129-40. PubMed ID: 23519546
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: results of a double-blind randomized multicentre trial.
    Grassi G, Trevano FQ, Facchini A, Toutouzas T, Chanu B, Mancia G.
    Blood Press Suppl; 2003 Dec 15; 2():35-40. PubMed ID: 14761075
    [Abstract] [Full Text] [Related]

  • 12. Nebivolol versus nifedipine in the treatment of essential hypertension: a double-blind, randomized, comparative trial.
    Van Nueten L, Lacourcière Y, Vyssoulis G, Korlipara K, Marcadet DM, Dupont AG, Robertson JI.
    Am J Ther; 1998 Jul 15; 5(4):237-43. PubMed ID: 10099065
    [Abstract] [Full Text] [Related]

  • 13. Vascular effects of nebivolol added to hydrochlorothiazide in African Americans with hypertension and echocardiographic evidence of diastolic dysfunction: the NASAA study.
    Khan BV, Rahman ST, Haque T, Merchant N, Bhaheetharan S, Harris J, Umar K, Wahi J, Ferdinand KC.
    J Cardiovasc Pharmacol Ther; 2012 Sep 15; 17(3):291-7. PubMed ID: 22388001
    [Abstract] [Full Text] [Related]

  • 14. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW.
    Clin Ther; 2009 Mar 15; 31(3):447-62. PubMed ID: 19393838
    [Abstract] [Full Text] [Related]

  • 15. Nebivolol vs amlodipine as first-line treatment of essential arterial hypertension in the elderly.
    Mazza A, Gil-Extremera B, Maldonato A, Toutouzas T, Pessina AC.
    Blood Press; 2002 Mar 15; 11(3):182-8. PubMed ID: 12126265
    [Abstract] [Full Text] [Related]

  • 16. Nebivolol induces parallel improvement of left ventricular filling pressure and coronary flow reserve in uncomplicated arterial hypertension.
    Galderisi M, D'Errico A, Sidiropulos M, Innelli P, de Divitiis O, de Simone G.
    J Hypertens; 2009 Oct 15; 27(10):2108-15. PubMed ID: 19564794
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of nebivolol: does age matter? A retrospective analysis of three randomized, placebo-controlled trials in stage I-II hypertension.
    Germino FW, Lin Y, Pejović V, Bowen L.
    Ther Adv Cardiovasc Dis; 2012 Oct 15; 6(5):185-99. PubMed ID: 23008339
    [Abstract] [Full Text] [Related]

  • 18. Nebivolol versus enalapril in essential hypertension: a long-term double-blind comparative trial.
    Van Nueten L, Rishøj Nielsen M, Vertommen C, Dupont AG, Robertson JI.
    Acta Clin Belg; 1999 Oct 15; 54(1):19-25. PubMed ID: 10192973
    [Abstract] [Full Text] [Related]

  • 19. Blood pressure effects of combined β-blocker and angiotensin-converting enzyme inhibitor therapy compared with the individual agents: a placebo-controlled study with nebivolol and lisinopril.
    Weber MA, Basile J, Stapff M, Khan B, Zhou D.
    J Clin Hypertens (Greenwich); 2012 Sep 15; 14(9):588-92. PubMed ID: 22947356
    [Abstract] [Full Text] [Related]

  • 20. Treatment of ambulatory hypertensives with nebivolol or hydrochlorothiazide alone and in combination. A randomized, double-blind, placebo-controlled, factorial-design trial.
    Lacourcière Y, Lefebvre J, Poirier L, Archambault F, Arnott W.
    Am J Hypertens; 1994 Feb 15; 7(2):137-45. PubMed ID: 8179848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.